Nexium IV (esomeprazole sodium)

NOVEMBER 01, 2005

AstraZeneca (Wilmington, Del) recently received FDA approval for Nexium IV for injection. The product is indicated for intravenous (IV) infusion or injection for the short-term treatment (up to 10 days) of gastroesophageal reflux disease in patients with a history of erosive esophagitis who are unable to take capsules. The recommended adult dosage regimen for the product is either 20 or 40 mg of Nexium IV given once daily by IV injection (=3 minutes) or IV infusion (10 to 30 minutes). Nexium IV is supplied as a freeze-dried powder containing 20 or 40 mg of esomeprazole per single-use vial. For more information, visit www.nexium-us.com, or call 800-237-8898.




SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.